API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
Details:
ANI Pharmaceuticals has acquired new drug applications for OXISTAT Lotion, VEREGEN Ointment, and Pandel Cream and the abbreviated new drug application for ApexiCon E Cream from Sandoz Inc. Pandel Cream will be transitioned later upon receiving the requisite approvals.
Lead Product(s): Oxiconazole Nitrate
Therapeutic Area: Infections and Infectious Diseases Product Name: Oxistat
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: ANI Pharmaceuticals Inc
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition April 06, 2021